Overview

Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)

Status:
Completed
Trial end date:
2008-05-12
Target enrollment:
Participant gender:
Summary
This study is to examine the safety of daptomycin in patients with End Stage Renal Disease.
Phase:
Phase 1
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin